These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33999136)
1. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Santella C; Bitton A; Filliter C; Bessissow T; Vutcovici M; Lakatos PL; Brassard P Inflamm Bowel Dis; 2022 Feb; 28(2):176-182. PubMed ID: 33999136 [TBL] [Abstract][Full Text] [Related]
2. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study. Côté-Daigneault J; Bessissow T; Nicolae MV; Nie R; Bitton A; Lakatos PL; Brassard P Inflamm Bowel Dis; 2019 Apr; 25(5):914-918. PubMed ID: 30295818 [TBL] [Abstract][Full Text] [Related]
3. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Long MD; Martin C; Sandler RS; Kappelman MD Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738 [TBL] [Abstract][Full Text] [Related]
4. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents. Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099 [TBL] [Abstract][Full Text] [Related]
5. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study. Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905 [TBL] [Abstract][Full Text] [Related]
6. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea. Chang K; Lee HS; Kim YJ; Kim SO; Kim SH; Lee SH; Song EM; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1928-1936.e2. PubMed ID: 29857150 [TBL] [Abstract][Full Text] [Related]
7. Incidence of herpes zoster in patients with inflammatory bowel disease. Calm A; Calafat M; González-Muñoza C; Cañete F; Roig C; Mañosa M; García-Planella E; Domènech E Gastroenterol Hepatol; 2024; 47(6):598-604. PubMed ID: 38316174 [TBL] [Abstract][Full Text] [Related]
8. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients. Khan N; Trivedi C; Kavani H; Lewis J; Yang YX Inflamm Bowel Dis; 2019 Jan; 25(2):345-351. PubMed ID: 29982646 [TBL] [Abstract][Full Text] [Related]
9. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Dai C; Jiang M; Huang YH Inflamm Bowel Dis; 2021 Nov; 27(12):e156. PubMed ID: 34259845 [No Abstract] [Full Text] [Related]
10. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Gupta G; Lautenbach E; Lewis JD Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240 [TBL] [Abstract][Full Text] [Related]
11. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications. Khan N; Shah Y; Trivedi C; Lewis JD Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309 [TBL] [Abstract][Full Text] [Related]
12. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease. Kochhar GS; Desai A; Caldera DO F; El Hachem S; Aoun E; Sandhu D; Mohan BP; Dulai PS; Farraye FA Vaccine; 2021 Jul; 39(30):4199-4202. PubMed ID: 34140170 [TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study. Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases. Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303 [TBL] [Abstract][Full Text] [Related]
16. Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need? Nugent Z; Singh H; Targownik LE; Bernstein CN Inflamm Bowel Dis; 2019 Feb; 25(3):532-540. PubMed ID: 30085137 [TBL] [Abstract][Full Text] [Related]
17. Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies. Ning L; Liu R; Li S; Shan G; Du H; Zhang J; Chen W; Zhang F; Yu J; Xu G Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):219-227. PubMed ID: 31650411 [TBL] [Abstract][Full Text] [Related]
18. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Desai A; Soni A; Hayney MS; Hashash JG; Kochhar GS; Farraye FA; Caldera F Inflamm Bowel Dis; 2024 Jul; 30(7):1094-1102. PubMed ID: 37540900 [TBL] [Abstract][Full Text] [Related]
19. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease. Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331 [TBL] [Abstract][Full Text] [Related]
20. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]